204 related articles for article (PubMed ID: 18788726)
21. Meayamycin inhibits pre-messenger RNA splicing and exhibits picomolar activity against multidrug-resistant cells.
Albert BJ; McPherson PA; O'Brien K; Czaicki NL; Destefino V; Osman S; Li M; Day BW; Grabowski PJ; Moore MJ; Vogt A; Koide K
Mol Cancer Ther; 2009 Aug; 8(8):2308-18. PubMed ID: 19671752
[TBL] [Abstract][Full Text] [Related]
22. Anticancer agents from the Australian tropical rainforest: Spiroacetals EBC-23, 24, 25, 72, 73, 75 and 76.
Dong L; Schill H; Grange RL; Porzelle A; Johns JP; Parsons PG; Gordon VA; Reddell PW; Williams CM
Chemistry; 2009 Oct; 15(42):11307-18. PubMed ID: 19750529
[TBL] [Abstract][Full Text] [Related]
23. Estrone derived steroidal diepoxide: biologically active compound and precursor of a stable steroidal A,B-spiro system.
Milic D; Kop T; Csanadi J; Juranic Z; Zizak Z; Gasic MJ; Solaja B
Steroids; 2009 Nov; 74(12):890-5. PubMed ID: 19538979
[TBL] [Abstract][Full Text] [Related]
24. Structure-based design of a novel synthetic spiroketal pyran as a pharmacophore for the marine natural product spongistatin 1.
Uckun FM; Mao C; Vassilev AO; Huang H; Jan ST
Bioorg Med Chem Lett; 2000 Mar; 10(6):541-5. PubMed ID: 10741549
[TBL] [Abstract][Full Text] [Related]
25. Enantioselective total syntheses of FR901464 and spliceostatin A and evaluation of splicing activity of key derivatives.
Ghosh AK; Chen ZH; Effenberger KA; Jurica MS
J Org Chem; 2014 Jun; 79(12):5697-709. PubMed ID: 24873648
[TBL] [Abstract][Full Text] [Related]
26. Enantioselective syntheses of FR901464 and spliceostatin A: potent inhibitors of spliceosome.
Ghosh AK; Chen ZH
Org Lett; 2013 Oct; 15(19):5088-91. PubMed ID: 24050251
[TBL] [Abstract][Full Text] [Related]
27. Total synthesis of the potent antitumor macrolides pladienolide B and D.
Kanada RM; Itoh D; Nagai M; Niijima J; Asai N; Mizui Y; Abe S; Kotake Y
Angew Chem Int Ed Engl; 2007; 46(23):4350-5. PubMed ID: 17437311
[No Abstract] [Full Text] [Related]
28. A Carbohydrate-Derived Splice Modulator.
Dhar S; La Clair JJ; León B; Hammons JC; Yu Z; Kashyap MK; Castro JE; Burkart MD
J Am Chem Soc; 2016 Apr; 138(15):5063-8. PubMed ID: 27058259
[TBL] [Abstract][Full Text] [Related]
29. Design, Synthesis and Biological Evaluation of Highly Potent Simplified Archazolids.
Rivière S; Vielmuth C; Ennenbach C; Abdelrahman A; Lemke C; Gütschow M; Müller CE; Menche D
ChemMedChem; 2020 Jul; 15(14):1348-1363. PubMed ID: 32363789
[TBL] [Abstract][Full Text] [Related]
30. Structural Basis of Splicing Modulation by Antitumor Macrolide Compounds.
Cretu C; Agrawal AA; Cook A; Will CL; Fekkes P; Smith PG; Lührmann R; Larsen N; Buonamici S; Pena V
Mol Cell; 2018 Apr; 70(2):265-273.e8. PubMed ID: 29656923
[TBL] [Abstract][Full Text] [Related]
31. Novel spiropyrazolone antitumor scaffold with potent activity: Design, synthesis and structure-activity relationship.
Wu S; Li Y; Xu G; Chen S; Zhang Y; Liu N; Dong G; Miao C; Su H; Zhang W; Sheng C
Eur J Med Chem; 2016 Jun; 115():141-7. PubMed ID: 27016707
[TBL] [Abstract][Full Text] [Related]
32. Novel spirobicyclic artemisinin analogues (artemalogues): Synthesis and antitumor activities.
Liu G; Song S; Shu S; Miao Z; Zhang A; Ding C
Eur J Med Chem; 2015 Oct; 103():17-28. PubMed ID: 26318055
[TBL] [Abstract][Full Text] [Related]
33. Potent in vitro and in vivo anticancer activities of des-methyl, des-amino pateamine A, a synthetic analogue of marine natural product pateamine A.
Kuznetsov G; Xu Q; Rudolph-Owen L; Tendyke K; Liu J; Towle M; Zhao N; Marsh J; Agoulnik S; Twine N; Parent L; Chen Z; Shie JL; Jiang Y; Zhang H; Du H; Boivin R; Wang Y; Romo D; Littlefield BA
Mol Cancer Ther; 2009 May; 8(5):1250-60. PubMed ID: 19417157
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and biological evaluation of 10,11-dihydrodictyostatin, a potent analogue of the marine anticancer agent dictyostatin.
Paterson I; Gardner NM; Poullennec KG; Wright AE
J Nat Prod; 2008 Mar; 71(3):364-9. PubMed ID: 18081257
[TBL] [Abstract][Full Text] [Related]
35. Medicinal chemistry of dihydropyran-based medium ring macrolides related to aspergillides: selective inhibition of PI3Kα.
Lambu MR; Kumar S; Yousuf SK; Sharma DK; Hussain A; Kumar A; Malik F; Mukherjee D
J Med Chem; 2013 Aug; 56(15):6122-35. PubMed ID: 23845251
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and biological evaluation of (+)-neopeltolide analogues: importance of the oxazole-containing side chain.
Fuwa H; Noguchi T; Kawakami M; Sasaki M
Bioorg Med Chem Lett; 2014 Jun; 24(11):2415-9. PubMed ID: 24792465
[TBL] [Abstract][Full Text] [Related]
37. Design and synthesis of novel tetrahydro-2H-Pyrano[3,2-c]pyridazin-3(6H)-one derivatives as potential anticancer agents.
Al-Tel TH
Eur J Med Chem; 2010 Dec; 45(12):5724-31. PubMed ID: 20884086
[TBL] [Abstract][Full Text] [Related]
38. Synthetic and biological studies on the spiro-mamakone system.
Murphy AC; Devenish SR; Muscroft-Taylor AC; Blunt JW; Munro MH
Org Biomol Chem; 2008 Oct; 6(20):3854-62. PubMed ID: 18843418
[TBL] [Abstract][Full Text] [Related]
39. Structure-activity relationship for FR901464: a versatile method for the conversion and preparation of biologically active biotinylated probes.
Motoyoshi H; Horigome M; Ishigami K; Yoshida T; Horinouchi S; Yoshida M; Watanabe H; Kitahara T
Biosci Biotechnol Biochem; 2004 Oct; 68(10):2178-82. PubMed ID: 15502365
[TBL] [Abstract][Full Text] [Related]
40. 4-aryl/heteroaryl-4H-fused Pyrans as Anti-proliferative Agents: Design, Synthesis and Biological Evaluation.
Kumar D; Singh G; Sharma P; Qayum A; Mahajan G; Mintoo MJ; Singh SK; Mondhe DM; Bedi PMS; Jain SK; Gupta GK
Anticancer Agents Med Chem; 2018; 18(1):57-73. PubMed ID: 28925877
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
